And Novartis has shipped more than 36 million doses of Fluvirin in the US, a 25 percent increase over the previous year, according to a spokeswoman.
FORBES: The Flu Season Is A Shot In The Arm For Vaccine Makers?
应用推荐
模块上移
模块下移
不移动